Dimethpyrindene and a New Antihistamine Hs 592 (Sandoz) in the Treatment of Severe Chronic Urticaria

Søbye, P; Ulrich, J

doi:10.1111/j.1398-9995.1968.tb04045.x

Cited by 2 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sobye & Ulrich (5) compared Dimetinden with Clemastine in patients suffering from chronic urticaria, and demonstrated Clemastine to be more effective (5). Tbe pharmacological and preliminary clinical experiments done with HC 20-511 showed this antihistamine to be faster acting and more effective than Clemastine when equal doses are compared…”

Section: Discussionmentioning

confidence: 99%

“…When investigating the clinical efficacy of antihistaminic drugs, one uses patient groups with either allergic respiratory diseases or allergic and pruritic dermatoses. Among the dermatoses, the effectiveness of an antihistamine drug can best and most reliably be demonstrated in chronic urticaria (5). Dimetinden (Fenistil) or dimethpyrindene maleate is an antihistamine, which has been on the market for over 10 years, and has been widely used in many countries.…”

mentioning

confidence: 99%

“…The new antihistamine, HC 20-511, is the hydrogen fumarate of 4-( i-methyl-4-piperidylidene)-4H-benzo [4,5] cyclohepta[i,2-b]thiophene-io (9H)-one ( Fig. i).…”

mentioning

confidence: 99%

See 2 more Smart Citations

A New Antihistamine Hc 20‐511* Compared With Dimetinden (Fenistil Retard®) in the Treatment of Chronic Urticaria and Other Pruritic Dermatoses

Kcokkanen

1975

Allergy

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

A New Antihistamine Hc 20‐511* Compared With Dimetinden (Fenistil Retard®) in the Treatment of Chronic Urticaria and Other Pruritic Dermatoses

Kcokkanen

1975

Allergy

View full text Add to dashboard Cite

H1-antihistamines for chronic spontaneous urticaria

Sharma

Bennett

Cohen

et al. 2014

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Background Chronic spontaneous urticaria (CSU) is characterised by the development of crops of red, itchy, raised weals or hives with no identifiable external cause. Objectives To assess the effects of H1-antihistamines for CSU. Search methods We searched the following databases up to June 2014: Cochrane Skin Group Specialised Register, CENTRAL (2014, Issue 5), MED-LINE (from 1946), EMBASE (from 1974) and PsycINFO (from 1806). We searched five trials registers and checked articles for references to relevant randomised controlled trials. Selection criteria We included randomised controlled trials of H1-antihistamines for CSU. Interventions included single therapy or a combination of H1-antihistamines compared with no treatment (placebo) or another active pharmacological compound at any dose. Data collection and analysis We used standard methodological procedures as expected by The Cochrane Collaboration. Our primary outcome measures were proportion of participants with complete suppression of urticaria: 'good or excellent' response, 50% or greater improvement in quality of life measures, and adverse events. We present risk ratios (RR) with 95% confidence intervals (CIs). H1-antihistamines for chronic spontaneous urticaria (Review)

show abstract

Dimethpyrindene and a New Antihistamine Hs 592 (Sandoz) in the Treatment of Severe Chronic Urticaria

Cited by 2 publications

References 3 publications

A New Antihistamine Hc 20‐511* Compared With Dimetinden (Fenistil Retard®) in the Treatment of Chronic Urticaria and Other Pruritic Dermatoses

A New Antihistamine Hc 20‐511* Compared With Dimetinden (Fenistil Retard®) in the Treatment of Chronic Urticaria and Other Pruritic Dermatoses

H1-antihistamines for chronic spontaneous urticaria

Contact Info

Product

Resources

About